col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


27 Results       Page 1

 [1] 
Mary Ann Liebert: Diabetes Technology & Therapeutics
  original article Date Title Authors   All Authors
1 [GO] 2023―Mar―29 Similar time course of humoral response to SARS-CoV-2 mRNA vaccines in people with and without Type 1 diabetes Xiaofan Jia, Fran Dong, Laura Pyle, Aaron W Michels, Liping Yu, Marian J Rewers
2 [GO] 2022―Apr―27 COVID-19 Pandemic and Diabetes Care Satish K. Garg, Erika Rodriguez
3 [GO] 2021―Dec―22 Use and Perception of Telemedicine in People with Type 1 Diabetes during the COVID-19 Pandemic: A One Year Follow-Up Sam Scott, Federico Fontana, Simon Helleputte, Jordan Pickles, Markus Laimer, Thomas Zueger, Christoph Stettler
4 [GO] 2021―Sep―15 Improvement in Mean CGM Glucose in Young People with Type 1 Diabetes during One Year of the COVID-19 Pandemic Tara Kaushal, Liane J Tinsley, Lisa K Volkening, Louise Ambler-Osborn, Lori MB Laffel
5 [GO] 2021―Sep―15 Telemetric continuous glucose monitoring during the COVID-19 pandemic in isolated hospitalized patients in Denmark - a randomized controlled exploratory trial Carina Kirstine Klarskov, Nicole Avlund Windum, Mikkel Thor Olsen, Arnold Matuvo Dungu, Andreas Kryger Jensen, Birgitte Lindegaard, et al. (+2)
6 [GO] 2021―Jun―04 A worldwide perspective on COVID-19 and diabetes management in 22,820 children from the SWEET project: diabetic ketoacidosis rates increase and glycemic control is maintained Thomas Danne, Stefanie Lanzinger, Martin Isaac de Bock, Erinn T. Rhodes, Guy Todd Alonso, Pascal Barat, et al. (+6)
7 [GO] 2021―Jun―01 COVID-19 Pandemic and Virtual Clinics for Diabetes Care Satish K. Garg, Trenton Reinicke
8 [GO] 2021―May―27 Youth with Type 1 Diabetes had Improvement in Continuous Glucose Monitoring Metrics During the COVID-19 Pandemic Fatema Abdulhussein, Hannah Chesser, W. John Boscardin, Jenise C Wong, Stephen Gitelman
9 [GO] 2021―Apr―14 Adoption of Telemedicine for Type 1 Diabetes Care During the COVID-19 Pandemic Joyce Lee, Emily Carlson, Anastasia Albanese-O'Neill, Carla Demeterco Berggren, Sarah Corathers, Francesco Vendrame, et al. (+8)
10 [GO] 2021―Apr―09 Letter to the Editor: Increased prevalence of diabetic ketoacidosis among Colorado children at diagnosis of type 1 diabetes during the COVID-19 pandemic lockdown resolves after reopening Guy Todd Alonso, Chelsea Murphy, Laura Pyle, Sarah Thomas, Rebecca Ohman-Hanson, arleta rewers
11 [GO] 2021―Feb―05 Prevalence of SARS-CoV-2 Antibodies in Children and Adults with Type 1 Diabetes Xiaofan Jia, Patricia Gesualdo, Cristy Geno Rasmussen, Aimon A Alkanani, Ling He, Fran Dong, et al. (+3)
12 [GO] 2021―Jan―20 Real-time CGM (rtCGM) during the COVID-19 Pandemic and its Impact on Time in Range Joost van der Linden, John B Welsh, Irl B Hirsch, Satish K Garg
13 [GO] 2021―Jan―15 Impact of COVID-19 on Health Economics and Technology in Diabetes Care: Use cases of Real-Time Continuous Glucose Monitoring to Transform Healthcare During a Global Pandemic Sandip Garg, Gregory Norman
14 [GO] 2020―Dec―18 Remote Glucose Monitoring Platform for Multiple Simultaneous Patients at Coronavirus Disease 2019 Intensive Care Units: Case Report Including Adults and Children Fabricio Garelli, Nicolás Rosales, Emilia Fushimi, Delfina Arambarri, Leandro Mendoza, Hernán De Battista, et al. (+11)
15 [GO] 2020―Nov―25 Factors related to improvement of glycemic control among adults with type 1 diabetes during lockdown due to COVID-19 Óscar Moreno-Domínguez, Noemí González-Pérez de Villar, Beatriz Barquiel, Natalia Hillman, Ruth Gaspar-Lafuente, Montserrat Arévalo-Gómez, Lucrecia Herranz
16 [GO] 2020―Nov―24 Glycemic Control of Patients with Type 1 Diabetes Using an Insulin Pump Before and During the COVID-19-Associated Quarantine Aikaterini Barmpagianni, Vaia Lambadiari, Athanasia Papazafiropoulou, Aikaterini Kountouri, Athina Stergiou, Andreas Melidonis, Stavros Liatis
17 [GO] 2020―Sep―01 Important Changes that May Affect Telehealth Policy During the COVID-19 Pandemic Carol Yarbrough
18 [GO] 2020―Aug―05 Retraction of: No Deleterious Effect of Lockdown Due to COVID-19 Pandemic on Glycaemic Control, Measured by Glucose Monitoring, in Adults with Type 1 Diabetes. Beato-Vibora PI. Diabetes Technol Ther 2020; epub DOI: 10.1089/dia.2020.0184
19 [GO] 2020―Jul―17 The Effectiveness of Virtual Training on the MiniMedTM 670G system in people with type 1 diabetes (T1D) during the COVID-19 Pandemic Robert Vigersky, Kevin Velado, Alex Zhong, Pratik Agrawal, Toni L Cordero
20 [GO] 2020―Jul―08 Usefulness and safety of remote continuous glucose monitoring for a severe COVID-19 patient with diabetes Emi Ushigome, Masahiro Yamazaki, Masahide Hamaguchi, Takamasa Ito, Shin Matsubara, Yasuhiro Tsuchido, et al. (+4)
21 [GO] 2020―May―18 Glycemic control in type 1 diabetes mellitus during COVID-19 quarantine and the role of in-home physical activity Gianluca Tornese, Viola Ceconi, Lorenzo Monasta, Claudia Carletti, Elena Faleschini, Egidio Barbi
22 [GO] 2020―May―12 Managing Diabetes in Pregnancy before, during and after COVID-19 Helen Murphy
23 [GO] 2020―May―12 Inpatient Transition to Virtual Care During COVID-19 Pandemic Morgan S. Jones, April L. Goley, Bonnie E. Alexander, Scott B. Keller, Marie M. Caldwell, John B. Buse
24 [GO] 2020―May―12 No deleterious effect of lockdown due to COVID-19 pandemic on glycaemic control, measured by glucose monitoring, in adults with type 1 diabetes Pilar Isabel Beato-Víbora
25 [GO] 2020―May―11 Role of Non-Profit Organization During COVID-19 for Diabetes Care: Healthcare Inequities and Role of Virtual Specialty Clinic David Panzirer
26 [GO] 2020―May―08 The Silver Lining to COVID-19: Avoiding Diabetic Ketoacidosis Admissions with Telehealth Anne L. Peters, Satish Garg
27 [GO] 2020―Apr―17 Managing New-Onset Type 1 Diabetes During the COVID-19 Pandemic: Challenges and Opportunities Satish K. Garg, David Rodbard, Irl B. Hirsch, Gregory P. Forlenza
 [1] 

27 Results       Page 1


[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.004 sec